PTPRN and colorectal carcinoma: In CRC, elevated PTPRN is associated with reduced survival, and its knockdown has been shown to suppress invasiveness in vitro and reduce liver metastasis in vivo by modulating epithelial–mesenchymal transition and impairing insulin receptor signaling [11].